2,220
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Porphyromonas, Treponema, and Mogibacterium promote IL8/IFNγ/TNFα-based pro-inflammation in patients with medication-related osteonecrosis of the jaw

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Article: 1851112 | Received 11 Aug 2020, Accepted 11 Nov 2020, Published online: 23 Nov 2020

References

  • Ruggiero SL, Dodson TB, Fantasia J, et al. Association of, S. Maxillofacial, American association of oral and maxillofacial surgeons position paper on medication-related osteonecrosis of the jaw–2014 update. J Oral Maxillofac Surg. 2014;72(10):1938–7.
  • Saia G, Blandamura S, Bettini G, et al. Occurrence of bisphosphonate-related osteonecrosis of the jaw after surgical tooth extraction. J Oral Maxillofac Surg. 2010;68(4):797–804.
  • Rao NJ, Wang JY, Yu RQ, et al. Role of periapical diseases in medication-related osteonecrosis of the jaws. Biomed Res Int. 2017;2017:1560175.
  • Li CL, Lu WW, Seneviratne CJ, et al. Role of periodontal disease in bisphosphonate-related osteonecrosis of the jaws in ovariectomized rats. Clin Oral Implants Res. 2016;27(1):1–6.
  • Song M, Alshaikh A, Kim T, et al. Preexisting periapical inflammatory condition exacerbates tooth extraction-induced bisphosphonate-related osteonecrosis of the jaw lesions in mice. J Endod. 2016;42(11):1641–1646.
  • Schipmann S, Metzler P, Rossle M, et al. Osteopathology associated with bone resorption inhibitors - which role does Actinomyces play? A presentation of 51 cases with systematic review of the literature. J Oral Pathol Med. 2013;42(8):587–593.
  • Aghaloo TL, Kang B, Sung EC, et al. Periodontal disease and bisphosphonates induce osteonecrosis of the jaws in the rat. J Bone Miner Res. 2011;26(8):1871–1882.
  • Bolette A, Lecloux G, Rompen E, et al. Influence of induced infection in medication-related osteonecrosis of the jaw development after tooth extraction: A study in rats. J Craniomaxillofac Surg. 2019;47(2):349–356.
  • De Bruyn L, Coropciuc R, Coucke W, et al. Microbial population changes in patients with medication-related osteonecrosis of the jaw treated with systemic antibiotics. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125(3):268–275.
  • Pushalkar S, Li X, Kurago Z, et al. Oral microbiota and host innate immune response in bisphosphonate-related osteonecrosis of the jaw. Int J Oral Sci. 2014;6(4):219–226.
  • Mawardi H, Giro G, Kajiya M, et al. A role of oral bacteria in bisphosphonate-induced osteonecrosis of the jaw. J Dent Res. 2011;90(11):1339–1345.
  • Akashi M, Kusumoto J, Takeda D, et al. A literature review of perioperative antibiotic administration in surgery for medication-related osteonecrosis of the jaw. Oral Maxillofac Surg. 2018;22(4):369–378.
  • Ji X, Pushalkar S, Li Y, et al. Antibiotic effects on bacterial profile in osteonecrosis of the jaw. Oral Dis. 2012;18(1):85–95.
  • Wang Y, Qian PY. Conservative fragments in bacterial 16S rRNA genes and primer design for 16S ribosomal DNA amplicons in metagenomic studies. PLoS One. 2009;4(10):e7401.
  • Owosho AA, Liang STY, Sax AZ, et al. Medication-related osteonecrosis of the jaw: an update on the memorial sloan kettering cancer center experience and the role of premedication dental evaluation in prevention. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125(5):440–445.
  • De Ceulaer J, Tacconelli E, Vandecasteele SJ. Actinomyces osteomyelitis in bisphosphonate-related osteonecrosis of the jaw (BRONJ): the missing link? Eur J Clin Microbiol. 2014;33(11):1873–1880.
  • Cerrato A, Zanette G, Boccuto M, et al. Actinomyces and MRONJ: A retrospective study and a literature review. J Stomatol Oral Maxillofac Surg. 2020. DOI:https://doi.org/10.1016/j.jormas.2020.07.012
  • Ermer MA, Kottmann SC, Otten JE, et al. In vitro investigation of the antimicrobial effect of three bisphosphonates against different bacterial strains. J Oral Maxillofac Surg. 2018;76(3):553–560.
  • Wei X, Pushalkar S, Estilo C, et al. Molecular profiling of oral microbiota in jawbone samples of bisphosphonate-related osteonecrosis of the jaw. Oral Dis. 2012;18(6):602–612.
  • Hidaka K, Mikuni-Takagaki Y, Wada-Takahashi S, et al. Low-intensity pulsed ultrasound prevents development of bisphosphonate-related osteonecrosis of the jaw-like pathophysiology in a rat model. Ultrasound Med Biol. 2019;45(7):1721–1732.
  • Velusamy SK, Sampathkumar V, Ramasubbu N, et al. Aggregatibacter actinomycetemcomitans colonization and persistence in a primate model. Proc Natl Acad Sci U S A. 2019;116(44):22307–22313.
  • Robertson D, Smith AJ. The microbiology of the acute dental abscess. J Med Microbiol. 2009;58(Pt 2):155–162.
  • Hong B-Y, Sobue T, Choquette L, et al. Chemotherapy-induced oral mucositis is associated with detrimental bacterial dysbiosis. Microbiome. 2019;7(1):66.
  • Kim T, Kim S, Song M, et al. Removal of pre-existing periodontal inflammatory condition before tooth extraction ameliorates medication-related osteonecrosis of the jaw–like lesion in mice. Am J Pathol. 2018;188(10):2318–2327.
  • Movila A, Mawardi H, Nishimura K, et al. Possible pathogenic engagement of soluble Semaphorin 4D produced by gamma delta T cells in medication-related osteonecrosis of the jaw (MRONJ). Biochem Biophys Res Commun. 2016;480(1):42–47.
  • Li Y, Xu J, Mao L, et al. Allogeneic mesenchymal stem cell therapy for bisphosphonate-related jaw osteonecrosis in Swine. Stem Cells Dev. 2013;22(14):2047–2056.
  • Masuda T, Deng X, Tamai R. Mouse macrophages primed with alendronate down-regulate monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1 alpha (MIP-1 alpha) production in response to Toll-like receptor (TLR) 2 and TLR4 agonist via Smad3 activation. Int Immunopharmacol. 2009;9(9):1115–1121.